SCOPA 2022: A look into sleep apnea and the eye

Video

Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Sleep apnea and the eye."

Brad Sutton, OD, FAAO, FORS, clinical professor at Indiana University School of Optometry, and service chief of the Indianapolis Eye Care Center speaks with Optometry Times® editor Kassi Jackson, sharing highlights from his presentation," which he presented during this year's South Carolina Optometric Physicians Association's (SCOPA) annual meeting in Hilton Head.

This transcript has been lightly edited for clarity:

Brad Sutton, OD, FAAO, FORS:

The goal is to talk about systemic sleep apnea and all of the things that that does to people—to drive cardiovascular disease and all the increased risk, that having sleep apnea—and having it undiagnosed and untreated—has for your cardiovascular health.

[I will also talk] about ocular conditions that sleep apnea has a role in. Sleep apnea is highly linked to things such as nonarteritic ischemic optic neuropathy, and even glaucoma in some patients, floppy eyelid syndrome, and lots of other things as well. So the goal is to cover pretty extensively sleep apnea, how it's diagnosed, how its treated, how it relates to cardiovascular disease in this country, and then also how it relates to certain eye problems and how we manage those.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.